Holdings (as at 2026-05-11)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Organon & Co. 3.87%
Humana Inc. 3.44%
Elevance Health Inc. 2.83%
DaVita Inc. 2.81%
Exelixis, Inc. 2.52%
Solventum Corporation 2.47%
Molina Healthcare, Inc. 2.41%
Biogen Inc. 2.35%
The Cigna Group 2.35%
Incyte Corporation 2.31%
Universal Health Services, Inc. (Class B) 2.04%
Regeneron Pharmaceuticals, Inc. 2.01%
HCA Healthcare, Inc. 1.95%
Chemed Corporation 1.94%
Globus Medical, Inc. (Class A) 1.93%
Zimmer Biomet Holdings, Inc. 1.91%
Bio-Rad Laboratories, Inc. (Class A) 1.90%
Cardinal Health, Inc. 1.88%
Encompass Health Corporation 1.88%
Tenet Healthcare Corporation 1.77%
Ionis Pharmaceuticals, Inc. 1.74%
Masimo Corporation 1.74%
Penumbra, Inc. 1.70%
United Therapeutics Corporation 1.67%
Amgen Inc. 1.63%
Merck & Co., Inc. 1.61%
Pfizer Inc. 1.60%
Becton, Dickinson and Company 1.58%
Illumina, Inc. 1.51%
Revvity, Inc. 1.47%
QIAGEN N.V. 1.42%
Natera, Inc. 1.30%
Quest Diagnostics Incorporated 1.26%
Gilead Sciences, Inc. 1.25%
Labcorp Holdings Inc. 1.25%
UnitedHealth Group Incorporated 1.23%
Henry Schein, Inc. 1.22%
Bristol-Myers Squibb Company 1.20%
Steris Plc 1.19%
Certara, Inc. 1.17%
Sarepta Therapeutics, Inc. 1.16%
ResMed Inc. 1.15%
GE HealthCare Technologies Inc. 1.13%
Medtronic Plc 1.12%
Insmed Incorporated 1.10%
The Cooper Companies, Inc. 1.08%
Waters Corporation 1.02%
Neurocrine Biosciences, Inc. 0.99%
Eli Lilly and Company 0.91%
Halozyme Therapeutics, Inc. 0.89%
IQVIA Holdings Inc. 0.88%
Agilent Technologies, Inc. 0.85%
Align Technology, Inc. 0.83%
BioMarin Pharmaceutical Inc. 0.81%
Thermo Fisher Scientific Inc. 0.80%
Johnson & Johnson 0.79%
Medline Inc. (Class A) 0.77%
Medpace Holdings, Inc. 0.76%
Abbott Laboratories 0.70%
Zoetis Inc. 0.56%
West Pharmaceutical Services, Inc. 0.52%
Royalty Pharma Plc (Class A) 0.44%
Sotera Health Company 0.44%
Vertex Pharmaceuticals Incorporated 0.40%
Viking Therapeutics, Inc. 0.40%
Edwards Lifesciences Corporation 0.39%
Envista Holdings Corporation 0.39%
IDEXX Laboratories, Inc. 0.38%
DexCom, Inc. 0.38%
AbbVie Inc. 0.38%
Intuitive Surgical, Inc. 0.37%
Veeva Systems Inc. (Class A) 0.37%
Danaher Corporation 0.36%
Stryker Corporation 0.35%
Boston Scientific Corporation 0.35%
Alnylam Pharmaceuticals, Inc. 0.35%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.